Rubitection

AI Care Management System for Chronic Deadly Wounds (diabetic foot ulcers and bedsores)

https://wefunder.com/rubitection

Total raised on Wefunder: 108800

Total investors: 48

Quick facts

  • $26 billion total market that is growing to address the aging population
  • Investor backed including AARP Agetech collaborative totaling $800K to date
  • Won several awards including AARP Agetech, Boston Scientific Connected Patient, and She Loves Tech
  • Have a pipeline of clinical partners including Baylor School of Medicine
  • Improves care and addresses a health disparity for people of color
  • Built a functional prototype and collected initial positive patient data
  • We have interest from 5 corporate partners
  • Two issued patents which protect our $26 billion market

Team profiles

Featured investor profiles

Rubitection

AI Care Management System for Chronic Deadly Wounds (diabetic foot ulcers and bedsores)

Funded badge
Last Funded May 2025

$408,800

raised from 48 investors

What Investors Say

LEAD INVESTOR
Invested $5,000 this round
It is hard to believe, but the technology for early detection of deep wounds is limited. Whether it is the early formation of diabetic ulcers, pediatric injuries, or the initial stages of bed sores in patients, these conditions are often difficult to detect and can be costly for both patients and healthcare providers. Early identification of wounds is critical for reducing mortality and significantly enhancing the quality of life for patients. Rubitection is at the forefront of revolutionizing early detection in chronic wound care, which costs over $26 billion annually. Leveraging advanced AI technology, Rubitection stands as a pivotal solution in the healthcare landscape, offering an affordable answer to this costly challenge. As the lead investor, I am excited to be part of this necessary innovation, bringing early wound detection to every hospital, skilled nursing facility, and doctor’s office.
What People Say